Wealthfront Advisers’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.09M | Sell |
18,176
-7,028
| -28% | -$2.97M | 0.01% | 378 |
|
|
2026
Q1 | $11.9M | Sell |
25,204
-5,099
| -17% | -$2.57M | 0.03% | 227 |
|
|
2025
Q4 | $14.1M | Buy |
30,303
+8,463
| +39% | +$3.93M | 0.03% | 187 |
|
|
2025
Q3 | $9.31M | Buy |
21,840
+396
| +2% | +$153K | 0.02% | 249 |
|
|
2025
Q2 | $8.22M | Buy |
21,444
+4,002
| +23% | +$1.44M | 0.02% | 257 |
|
|
2025
Q1 | $6.03M | Buy |
17,442
+3,088
| +22% | +$993K | 0.02% | 313 |
|
|
2024
Q4 | $4.31M | Sell |
14,354
-1,201
| -8% | -$420K | 0.01% | 359 |
|
|
2024
Q3 | $6.32M | Sell |
15,555
-124
| -0.8% | -$45.4K | 0.02% | 253 |
|
|
2024
Q2 | $5.04M | Buy |
15,679
+518
| +3% | +$168K | 0.02% | 267 |
|
|
2024
Q1 | $5.06M | Buy |
15,161
+790
| +5% | +$241K | 0.02% | 261 |
|
|
2023
Q4 | $3.89M | Sell |
14,371
-2,953
| -17% | -$730K | 0.01% | 293 |
|
|
2023
Q3 | $4.26M | Sell |
17,324
-242
| -1% | -$66.2K | 0.02% | 243 |
|
|
2023
Q2 | $5.33M | Buy |
17,566
+116
| +0.7% | +$32.3K | 0.02% | 202 |
|
|
2023
Q1 | $4.6M | Buy |
17,450
+658
| +4% | +$167K | 0.02% | 220 |
|
|
2022
Q4 | $4.03M | Sell |
16,792
-485
| -3% | -$109K | 0.02% | 241 |
|
|
2022
Q3 | $3.17M | Sell |
17,277
-1,236
| -7% | -$246K | 0.02% | 265 |
|
|
2022
Q2 | $3.11M | Buy |
18,513
+1,894
| +11% | +$407K | 0.02% | 277 |
|
|
2022
Q1 | $4.17M | Buy |
16,619
+5,634
| +51% | +$1.41M | 0.02% | 238 |
|
|
2021
Q4 | $2.82M | Sell |
10,985
-1,025
| -9% | -$251K | 0.01% | 318 |
|
|
2021
Q3 | $2.92M | Buy |
12,010
+7,079
| +144% | +$1.73M | 0.01% | 260 |
|
|
2021
Q2 | $1.02M | Buy |
4,931
+494
| +11% | +$101K | ﹤0.01% | 425 |
|
|
2021
Q1 | $836K | Buy |
4,437
+556
| +14% | +$98K | ﹤0.01% | 403 |
|
|
2020
Q4 | $638K | Buy |
3,881
+315
| +9% | +$46.1K | ﹤0.01% | 407 |
|
|
2020
Q3 | $445K | Sell |
3,566
-3
| -0.1% | -$371 | ﹤0.01% | 418 |
|
|
2020
Q2 | $346K | Sell |
3,569
-967
| -21% | -$101K | ﹤0.01% | 435 |
|
|
2020
Q1 | $408K | Sell |
4,536
-2,518
| -36% | -$326K | ﹤0.01% | 365 |
|
|
2019
Q4 | $1.04M | Buy |
7,054
+305
| +5% | +$41K | 0.01% | 312 |
|
|
2019
Q3 | $813K | Sell |
6,749
-1,827
| -21% | -$236K | 0.01% | 325 |
|
|
2019
Q2 | $1.16M | Sell |
8,576
-303
| -3% | -$38.3K | 0.01% | 244 |
|
|
2019
Q1 | $1.16M | Sell |
8,879
-797
| -8% | -$107K | 0.01% | 232 |
|
|
2018
Q4 | $1.2M | Buy |
+9,676
| New | +$1.3M | 0.01% | 204 |
|
Other funds holding HCA
Wealthfront Advisers's HCA Position: Q2 2026 in Review
Wealthfront Advisers reduced its HCA Healthcare (HCA) stake by 28% in Q2 2026, selling an estimated $2.97M and leaving 18,176 shares worth $7.09M. The position accounts for 0.01% of the portfolio, ranked #378.
Wealthfront Advisers first reported a position in HCA in Q4 2018 and has held it in 31 quarters since. The position peaked at $14.1M in Q4 2025. 979 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Wealthfront Advisers held 18,176 shares of HCA Healthcare worth $7.09M as of Q2 2026.
- Wealthfront Advisers sold 7,028 HCA Healthcare shares in Q2 2026, an estimated $2.97M.
- HCA Healthcare made up 0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #378 holding.
- Wealthfront Advisers first reported a position in HCA Healthcare in Q4 2018 and has held it in 31 quarters since.
- Wealthfront Advisers's HCA Healthcare position peaked at $14.1M in Q4 2025.
- 979 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.